Christopher R. Stone

Array ( [id] => 5361734 [patent_doc_number] => 20090036528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Multifunctional and combinational application of aspartame and or futhan' [patent_app_type] => utility [patent_app_number] => 12/220949 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8546 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036528.pdf [firstpage_image] =>[orig_patent_app_number] => 12220949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099659 [patent_doc_number] => 08563537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Camptothecin derivatives as chemoradiosensitizing agents' [patent_app_type] => utility [patent_app_number] => 12/124712 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30611 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12124712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840495 [patent_doc_number] => 20080280981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Tranexamic acid formulations' [patent_app_type] => utility [patent_app_number] => 12/220241 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6791 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280981.pdf [firstpage_image] =>[orig_patent_app_number] => 12220241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840331 [patent_doc_number] => 20080280817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'MODIFIED AMINO ACID FOR THE INHIBITION OF PLATELET AGGREGATION' [patent_app_type] => utility [patent_app_number] => 12/169184 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5075 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280817.pdf [firstpage_image] =>[orig_patent_app_number] => 12169184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555681 [patent_doc_number] => 08067582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function' [patent_app_type] => utility [patent_app_number] => 12/666423 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 77164 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067582.pdf [firstpage_image] =>[orig_patent_app_number] => 12666423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507818 [patent_doc_number] => 07915247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-03-29 [patent_title] => 'Methods of use of fenofibric acid' [patent_app_type] => utility [patent_app_number] => 12/141280 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37720 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915247.pdf [firstpage_image] =>[orig_patent_app_number] => 12141280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490915 [patent_doc_number] => 20090291986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'COMPOSITION AND METHOD OF TREATING FACIAL SKIN DEFECT' [patent_app_type] => utility [patent_app_number] => 12/125481 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6265 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291986.pdf [firstpage_image] =>[orig_patent_app_number] => 12125481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792798 [patent_doc_number] => 20080293772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'SALTS OF PICOTAMIDE' [patent_app_type] => utility [patent_app_number] => 12/124790 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3516 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293772.pdf [firstpage_image] =>[orig_patent_app_number] => 12124790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249265 [patent_doc_number] => 20100137354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'DERIVATIVES OF FLUORENE, ANTHRACENE, XANTHENE, DIBENZOSUBERONE AND ACRIDINE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/451313 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14372 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137354.pdf [firstpage_image] =>[orig_patent_app_number] => 12451313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873815 [patent_doc_number] => 20080200549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND PARACETAMOL AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/113171 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6065 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200549.pdf [firstpage_image] =>[orig_patent_app_number] => 12113171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872731 [patent_doc_number] => 20080199465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'IMMUNOSUPPRESSIVE COMBINATION AND ITS USE IN THE TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION' [patent_app_type] => utility [patent_app_number] => 12/107726 [patent_app_country] => US [patent_app_date] => 2008-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4701 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199465.pdf [firstpage_image] =>[orig_patent_app_number] => 12107726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4814052 [patent_doc_number] => 20080194683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Medicament for preventing and/or treating peripheral neuropathies' [patent_app_type] => utility [patent_app_number] => 12/078991 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7486 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194683.pdf [firstpage_image] =>[orig_patent_app_number] => 12078991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039478 [patent_doc_number] => 20110092527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => '4 (Pyrrolopyridinyl)pyrimidin-2-ylamine derivatives' [patent_app_type] => utility [patent_app_number] => 12/527671 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11635 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092527.pdf [firstpage_image] =>[orig_patent_app_number] => 12527671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280391 [patent_doc_number] => 20100119512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHODS OF DIAGNOSING, TREATING, AND PREVENTING INCREASED VASCULAR PERMEABILITY' [patent_app_type] => utility [patent_app_number] => 12/522625 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10204 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119512.pdf [firstpage_image] =>[orig_patent_app_number] => 12522625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752035 [patent_doc_number] => 20080160108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Method of treating muscular dystrophies with an inhibitor of histone deacetylase' [patent_app_type] => utility [patent_app_number] => 12/006497 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 4748 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160108.pdf [firstpage_image] =>[orig_patent_app_number] => 12006497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577740 [patent_doc_number] => 08343950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Quinazoline derivatives and methods of treatment' [patent_app_type] => utility [patent_app_number] => 11/957442 [patent_app_country] => US [patent_app_date] => 2007-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11682 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11957442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546770 [patent_doc_number] => 20090156647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Method for maintaining physiological pH levels during intensive physical exercise' [patent_app_type] => utility [patent_app_number] => 11/954635 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3309 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156647.pdf [firstpage_image] =>[orig_patent_app_number] => 11954635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786325 [patent_doc_number] => 20080139654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'ACETAMINOPHEN COMPOSITIONS HAVING MINIMIZED SIDE EFFECTS INCLUDING REDUCED HEPATOTOXICITY' [patent_app_type] => utility [patent_app_number] => 11/952556 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4908 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139654.pdf [firstpage_image] =>[orig_patent_app_number] => 11952556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870907 [patent_doc_number] => 08466283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/517875 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33164 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12517875 [rel_patent_id] =>[rel_patent_doc_number] =>)